Close

Can-Fite BioPharma (CANF) Receives USPTO Notice of Allowance for ED Treatment-Related Patent

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. MSFT
4. CMG
5. SPY
6. LRCX
7. INTC
8. IBM
9. SNAP
10. BA


Go back to Can-Fite BioPharma (CANF) Receives USPTO Notice of Allowance for ED Treatment-Related Patent
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 1.92 --0 (-0%)
Previous Close $1.92    52 Week High $3.89 
Open $1.92    52 Week Low $1.85 
Day High $1.92    P/E N/A 
Day Low $1.92    EPS $0.00 
Volume 65       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206